Is egg freezing worth the cost? An honest look at utilisation, regret, and realistic outcomes

The utilisation rate

The 2021 Fertility & Sterility cohort, the largest published utilisation dataset to date, found 38.1% of patients had returned to use their frozen eggs by the study cutoff. The remaining 61.9% had not yet used them, with the majority of that group having frozen too recently to have made the decision. Other published cohorts including UCLA reported even lower rates of 5.7% return-to-use within 5 to 7 years for 2014 to 2016 freezers.^[7][21]

Why utilisation is what it is. Many freezers conceive naturally before deciding to thaw. Some change their minds about children. Some change relationship circumstances. The eggs going unused is sometimes the best outcome (a natural-conception baby is the result everyone would have preferred) and sometimes a decision that the option no longer fits.

Per-egg success math

Per-egg live-birth probability ranges from roughly 6% to 12% per mature egg, varying with age at freezing and recipient factors at the time of use. For eggs frozen under 35, published cohort data points towards approximately 6 to 7% per egg.^[6][5]

Two practical implications. First, ten frozen eggs is not equivalent to a baby. A ten-egg freeze at age 32 represents a 50% to 60% probability of one live birth on a full-cycle thaw-and-transfer pathway, not a guarantee. Second, the per-egg drop with age is steep. Eggs frozen at 38 to 40 have approximately half the per-egg live-birth rate of eggs frozen at 30 to 34.

Regret data

Published patient-reported outcome surveys consistently show that women who froze eggs and did not return to use them generally do not regret the decision. The most common framing in regret surveys is "I am glad I had the option even though I did not use it." Among women who do report regret, the most common cited cause is cost rather than outcome. Decision-quality survey data from cohorts published in JARG and Fertility & Sterility consistently support this pattern.

Cases where the math is hard to justify

• Patient is already trying to conceive and the attempts are progressing
• Patient is over 42 with no specific medical urgency. ASRM 2023 ethics opinion notes the difficulty of meaningful probability assurance at this age band.^[20]
• Cannot afford the cost without significant high-APR debt. The expected-value math gets harder when interest cost compounds against an option that is exercised less than 50% of the time.
• Strong indication, after counselling, that the patient is unlikely to want a biological child later
• AMH and antral follicle count suggest expected yield per cycle is so low that three or more cycles would be needed without insurance coverage

Cases where the math is easier to justify

• Pre-cancer-treatment medical necessity (a different question entirely; insurance typically covers and the option preserves a natural-conception possibility that chemo or radiation may eliminate)
• Strong career-time-horizon mismatch with biological optimal age
• Employer benefit covers the majority of freeze and storage cost
• State insurance mandate makes medically necessary preservation effectively free
• Patient has clear preference for a biological child later and is already in the 30 to 35 window where one cycle suffices

A six-question self-assessment

Not a quiz with a result. Questions to think through with a partner, therapist, or reproductive endocrinologist before committing.

1. How important is having a biological child to me, on a 1 to 10 scale?
2. What is my realistic age at first attempt to use the eggs (not the date I plan to use them)?
3. Can I afford the freeze cost without significant debt or financial strain?
4. Do I have a partner or a sperm-source plan? If not, am I prepared for the donor pathway later?
5. What is my AMH and antral follicle count today, and what does my reproductive endocrinologist say about my likely yield?
6. Would I freeze again in 12 months if I don't freeze now?

Freeze younger or freeze sooner?

The two pressures pull in opposite directions. Freezing younger means better per-egg outcomes and lower per-target cost, but longer storage commitment and higher probability of eventually not using the eggs. Freezing sooner (at the latest reasonable age) reduces the chance of unused-egg waste but the per-egg yield and per-egg success drop with each year past 35. Neither pressure dominates universally. The honest framing: freeze when the option value is highest relative to the cumulative cost, which for most patients is the 30 to 35 age band, with employer or insurance coverage tilting the math earlier.

Related

• Cost by age, with per-age expected outcomes
• Use-side cost (the strike price)
• Multi-cycle math